HPWM
TXMD icon

Highland Private Wealth Management’s TherapeuticsMD TXMD Stock Holding History

Highland Private Wealth Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-214
Closed -$17K – 144
2020
Q3 		$17K Hold
214
– – ﹤0.01% 132
2020
Q2 		$13K Hold
214
– – ﹤0.01% 133
2020
Q1 		$11K Hold
214
– – ﹤0.01% 116
2019
Q4 		$26K Hold
214
– – 0.01% 131
2019
Q3 		$39K Hold
214
– – 0.01% 122
2019
Q2 		$28K Buy
+214
New +$38.4K 0.01% 126

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Highland Private Wealth Management's TXMD Position: Q4 2020 in Review

Highland Private Wealth Management sold out of TherapeuticsMD (TXMD) in Q4 2020, closing a stake of 214 shares — an estimated $17K sold.

Highland Private Wealth Management first reported a position in TXMD in Q2 2019 and held it in 6 quarters. The position peaked at $39K in Q3 2019. 159 funds tracked by Wall St. Rank hold TXMD as of Q4 2020.

  • Highland Private Wealth Management reported no remaining TherapeuticsMD position as of Q4 2020 after selling out during the quarter.
  • Highland Private Wealth Management sold 214 TherapeuticsMD shares in Q4 2020, an estimated $17K.
  • Highland Private Wealth Management first reported a position in TherapeuticsMD in Q2 2019 and held it in 6 quarters.
  • Highland Private Wealth Management's TherapeuticsMD position peaked at $39K in Q3 2019.
  • 159 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2020.

Based on Highland Private Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.